• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Vector Group Reports Second Quarter 2024 Financial Results

    7/31/24 4:45:00 PM ET
    $VGR
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $VGR alert in real time by email

    Montego maintains position as largest discount brand in the U.S.

    Second Quarter 2024 Highlights:

    • Consolidated revenues of $371.9 million, up 1.7% or $6.3 million compared to the prior year period.
      • Tobacco segment wholesale market share increased to 5.7% from 5.4% in the prior year period and retail market share remained at 5.8%, unchanged from the prior year period.
      • Montego wholesale and retail market share both increased to 4.1% from 3.4% and 3.5%, respectively, in the prior year period.
    • Operating income of $97.8 million, up 36.5% or $26.1 million compared to the prior year period.
      • Tobacco segment operating income of $102.9 million, up 37.0% or $27.8 million compared to the prior year period.
    • Adjusted EBITDA of $103.3 million, up 9.7% or $9.2 million compared to the prior year period.
      • Tobacco Adjusted EBITDA of $104.4 million, up 10.2% or $9.7 million compared to the prior year period.

    First Half 2024 Highlights:

    • Consolidated revenues of $696.5 million, down 0.5% or $3.3 million compared to the prior year period.
      • Tobacco segment revenues of $696.5 million, down 0.5% or $3.3 million compared to the prior year period.
      • Tobacco segment wholesale market share increased to 5.7% from 5.5% in the prior year period and retail market share remained at 5.8%.
      • Montego wholesale and retail market share both increased to 4.0% from 3.4% in the prior year period.
    • Operating income of $175.6 million, up 20.3% or $29.6 million compared to the prior year period.
      • Tobacco segment operating income of $185.9 million, up 21.0% or $32.2 million compared to the prior year period.
    • Adjusted EBITDA of $186.0 million, up 8.1% or $13.9 million compared to the prior year period.
      • Tobacco Adjusted EBITDA of $188.8 million, up 8.1% or $14.1 million compared to the prior year period.

     

    Vector Group Ltd. (NYSE:VGR) today announced financial results for the three and six months ended June 30, 2024.

    "Vector Group delivered strong performance in the second quarter bolstered by the impressive growth of our Montego brand," said Howard M. Lorber, President and Chief Executive Officer of Vector Group Ltd. "Montego's continued expansion as the largest discount brand in the U.S. highlights the effectiveness of our strategic approach, expert market analysis, and proven execution. We are confident in our ability to sustain our momentum in the second half of the year and to drive long-term value for our stockholders."

    GAAP Financial Results

    Three months ended June 30, 2024 and 2023. Second quarter 2024 revenues were $371.9 million, compared to $365.7 million in the second quarter of 2023. The Company recorded operating income of $97.8 million in the second quarter of 2024, compared to $71.6 million in the second quarter of 2023. Net income for the second quarter of 2024 was $54.2 million, or $0.34 per diluted common share, compared to $38.1 million, or $0.24 per diluted common share, in the second quarter of 2023.

    Six months ended June 30, 2024 and 2023. For the six months ended June 30, 2024, revenues were $696.5 million, compared to $699.8 million for the six months ended June 30, 2023. The Company recorded operating income of $175.6 million for the six months ended June 30, 2024, compared to $145.9 million for the six months ended June 30, 2023. Net income for the six months ended June 30, 2024 was $89.0 million, or $0.56 per diluted common share, compared to $72.8 million, or $0.46 per diluted common share, for the six months ended June 30, 2023.

    Non-GAAP Financial Measures

    Three months ended June 30, 2024 compared to the three months ended June 30, 2023

    Adjusted EBITDA (as described in Table 2 attached hereto) were $103.3 million for the second quarter of 2024, compared to $94.1 million for the second quarter of 2023.

    Adjusted Net Income (as described in Table 3 attached hereto) was $53.3 million, or $0.34 per diluted share, for the second quarter of 2024, compared to $50.8 million, or $0.32 per diluted share, for the second quarter of 2023.

    Adjusted Operating Income (as described in Table 4 attached hereto) was $97.9 million for the second quarter of 2024, compared to $89.7 million for the second quarter of 2023.

    Six months ended June 30, 2024 compared to the six months ended June 30, 2023

    Adjusted EBITDA (as described in Table 2 attached hereto) were $186.0 million for the six months ended June 30, 2024, compared to $172.2 million for the six months ended June 30, 2023.

    Adjusted Net Income (as described in Table 3 attached hereto) was $90.5 million, or $0.57 per diluted share, for the six months ended June 30, 2024, compared to $84.8 million, or $0.54 per diluted share, for the six months ended June 30, 2023.

    Adjusted Operating Income (as described in Table 4 attached hereto) was $175.7 million for the six months ended June 30, 2024, compared to $164.0 million for the six months ended June 30, 2023.

    Consolidated Balance Sheet

    Vector Group maintained significant liquidity at June 30, 2024 with cash and cash equivalents of $390.8 million, including $149.2 million of cash from the Tobacco segment, investment securities of $141.0 million and long-term investments of $46.8 million.

    Vector Group continued its longstanding history of paying a quarterly cash dividend in the second quarter of 2024. For the six months ended June 30, 2024, Vector Group returned a total of $63.9 million to stockholders at a quarterly rate of $0.20 per share of common stock.

    Tobacco Segment Financial Results

    For the second quarter of 2024, the Tobacco segment had revenues of $371.9 million, compared to $365.7 million for the second quarter of 2023. For the six months ended June 30, 2024, the Tobacco segment had revenues of $696.5 million, compared to $699.8 million for the six months ended June 30, 2023.

    Operating Income from the Tobacco segment was $102.9 million and $185.9 million for the three and six months ended June 30, 2024, respectively, compared to $75.1 million and $153.7 million for the three and six months ended June 30, 2023, respectively.

    Non-GAAP Financial Measures

    Tobacco Adjusted Operating Income (as described in Table 5 attached hereto) for the second quarter of 2024 was $103.0 million compared to $93.2 million for the second quarter of 2023. Tobacco Adjusted Operating Income for the six months ended June 30, 2024 was $186.0 million, compared to $171.8 million for the six months ended June 30, 2023.

    Operational Metrics

    For the second quarter of 2024, the Tobacco segment had conventional cigarette (wholesale) shipments of approximately 2.39 billion units, compared to 2.52 billion units for the second quarter of 2023. For the six months ended June 30, 2024, the Tobacco segment had conventional cigarette (wholesale) shipments of approximately 4.50 billion units, compared to 4.87 billion units for the six months ended June 30, 2023.

    According to data from Management Science Associates, Inc., for the second quarter of 2024, the Tobacco segment's wholesale market share increased to 5.7%, from 5.4% for the second quarter of 2023. For the six months ended June 30, 2024, the Tobacco segment's wholesale market share increased to 5.7%, from 5.5% for the six months ended June 30, 2023. For the second quarter of 2024, Montego's wholesale market share increased to 4.1%, from 3.4% for the second quarter of 2023. For the six months ended June 30, 2024, Montego's wholesale market share increased to 4.0%, from 3.4% for the six months ended June 30, 2023. The Tobacco segment's wholesale shipments in the second quarter of 2024 declined by 5.1% compared to the second quarter of 2023, while the industry's overall wholesale shipments declined by 10.5%. The Tobacco segment's wholesale shipments for the six months ended June 30, 2024 declined by 7.8% compared to the six months ended June 30, 2023, while the industry's overall wholesale shipments declined by 10.1%.

    According to data from Management Science Associates, Inc., for the second quarter of 2024, the Tobacco segment's retail market share remained at 5.8% compared to the second quarter of 2023. For the six months ended June 30, 2024, the Tobacco segment's retail market share remained at 5.8%, compared to the six months ended June 30, 2023. For the second quarter of 2024, Montego's retail market share increased to 4.1%, from 3.5% for the second quarter of 2023. For the six months ended June 30, 2024, Montego's retail market share increased to 4%, from 3.4% for the six months ended June 30, 2023. The Tobacco segment's retail shipments in the second quarter of 2024 declined by 9.6% compared to the second quarter of 2023, while the industry's overall retail shipments declined by 10.0%. The Tobacco segment's retail shipments for the six months ended June 30, 2024 declined by 9.1% compared to the six months ended June 30, 2023, while the industry's overall retail shipments declined by 9.5%.

    Non-GAAP Financial Measures

    Adjusted EBITDA, Adjusted Net Income, Adjusted Operating Income, Tobacco Adjusted Operating Income and Tobacco Adjusted EBITDA (the "Non-GAAP Financial Measures") are financial measures not prepared in accordance with generally accepted accounting principles ("GAAP"). The Company believes that the Non-GAAP Financial Measures are important measures that supplement discussions and analysis of its results of operations and enhance an understanding of its operating performance. The Company believes the Non-GAAP Financial Measures provide investors and analysts with a useful measure of operating results unaffected by differences in capital structures and ages of related assets among otherwise comparable companies.

    Management uses the Non-GAAP Financial Measures as measures to review and assess operating performance of the Company's business, and management does and investors should review both the overall performance (GAAP net income) and the operating performance (the Non-GAAP Financial Measures) of the Company's business. While management considers the Non-GAAP Financial Measures to be important, they should be considered in addition to, but not as substitutes for or superior to, other measures of financial performance prepared in accordance with GAAP, such as operating income, net income and cash flows from operations. In addition, the Non-GAAP Financial Measures are susceptible to varying calculations and the Company's measurement of the Non-GAAP Financial Measures may not be comparable to those of other companies.

    Reconciliations of Non-GAAP Financial Measures to the comparable GAAP financial results for the three and six months ended June 30, 2024 and 2023 are included in Tables 2 through 6.

    Conference Call to Discuss Second Quarter 2024 Results

    As previously announced, the Company will host a conference call and webcast on Thursday, August 1, 2024 at 8:00 AM (ET) to discuss its quarterly period and six months results. Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/50954. Please join the webcast at least ten minutes prior to the start time.

    A replay of the call will be available shortly after the call ends on August 1, 2024 through August 15, 2024 at https://www.webcaster4.com/Webcast/Page/2271/50954.

    About Vector Group Ltd.

    Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC, and New Valley LLC. Additional information concerning the Company is available on the Company's website, www.VectorGroupLtd.com.

    Investors and others should note that we may post information about the Company or its subsidiaries on our website at www.VectorGroupLtd.com and/or at the websites of those subsidiaries or, if applicable, on their accounts on LinkedIn, X or other social media platforms. It is possible that the postings or releases could include information deemed to be material information. Therefore, we encourage investors, the media and others interested in the Company to review the information we post on our website at www.VectorGroupLtd.com, on the websites of our subsidiaries and on their social media accounts.

    Forward-Looking and Cautionary Statements

    This press release includes forward-looking statements within the meaning of the federal securities law. All statements other than statements of historical or current facts made in this document are forward-looking. We identify forward-looking statements in this document by using words or phrases such as "anticipate," "believe," "estimate," "expect," "intend," "may be," "continue," "could," "potential," "objective," "plan," "seek," "predict," "project" and "will be" and similar words or phrases or their negatives. Forward-looking statements reflect our current expectations and are inherently uncertain. Actual results could differ materially for a variety of reasons.

    Risks and uncertainties that could cause our actual results to differ significantly from our current expectations are described in our 2023 Annual Report on Form 10-K and, when filed, in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. We undertake no responsibility to publicly update or revise any forward-looking statement except as required by applicable law.

    [Financial Tables Follow]

    TABLE 1

    VECTOR GROUP LTD. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS

    (Unaudited)

    (Dollars in Thousands, Except Per Share Amounts)

     

     

    Three Months Ended

     

    Six Months Ended

     

    June 30,

     

    June 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

    Revenues:

     

     

     

     

     

     

     

    Tobacco*

    $

    371,914

     

     

    $

    365,662

     

     

    $

    696,481

     

     

    $

    699,807

     

     

     

     

     

     

     

     

     

    Expenses:

     

     

     

     

     

     

     

    Cost of sales:

     

     

     

     

     

     

     

    Tobacco*

     

    244,594

     

     

     

    248,984

     

     

     

    462,495

     

     

     

    481,270

     

     

     

     

     

     

     

     

     

    Operating, selling, administrative and general expenses

     

    29,461

     

     

     

    26,930

     

     

     

    58,155

     

     

     

    54,222

     

    Litigation settlement and judgment expense

     

    73

     

     

     

    18,105

     

     

     

    264

     

     

     

    18,375

     

    Operating income

     

    97,786

     

     

     

    71,643

     

     

     

    175,567

     

     

     

    145,940

     

     

     

     

     

     

     

     

     

    Other income (expenses):

     

     

     

     

     

     

     

    Interest expense

     

    (26,583

    )

     

     

    (27,124

    )

     

     

    (54,032

    )

     

     

    (54,598

    )

    Loss on extinguishment of debt

     

    —

     

     

     

    (40

    )

     

     

    —

     

     

     

    (181

    )

    Equity in (losses) earnings from investments

     

    (641

    )

     

     

    959

     

     

     

    1,497

     

     

     

    800

     

    Equity in (losses) earnings from real estate ventures

     

    (1,213

    )

     

     

    2,954

     

     

     

    (11,934

    )

     

     

    1,061

     

    Other, net

     

    5,585

     

     

     

    4,791

     

     

     

    11,970

     

     

     

    8,411

     

    Income before provision for income taxes

     

    74,934

     

     

     

    53,183

     

     

     

    123,068

     

     

     

    101,433

     

    Income tax expense

     

    20,756

     

     

     

    15,094

     

     

     

    34,090

     

     

     

    28,603

     

     

     

     

     

     

     

     

     

    Net income

    $

    54,178

     

     

    $

    38,089

     

     

    $

    88,978

     

     

    $

    72,830

     

     

     

     

     

     

     

     

     

    Per basic common share:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income applicable to common shares

    $

    0.34

     

     

    $

    0.24

     

     

    $

    0.56

     

     

    $

    0.46

     

     

     

     

     

     

     

     

     

    Per diluted common share:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income applicable to common shares

    $

    0.34

     

     

    $

    0.24

     

     

    $

    0.56

     

     

    $

    0.46

     

    * Revenues and cost of sales include federal excise taxes of $120,452, $126,750, $226,275 and $244,568 for the three and six months ended June 30, 2024 and 2023, respectively.

    TABLE 2

    VECTOR GROUP LTD. AND SUBSIDIARIES

    RECONCILIATION OF ADJUSTED EBITDA

    (Unaudited)

    (Dollars in Thousands)

     

     

     

     

     

     

     

     

     

     

     

    LTM

     

    Year Ended

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

     

    December 31,

     

    June 30,

     

    June 30,

     

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

     

     

     

    Net income

    $

    199,674

     

     

    $

    183,526

     

     

    $

    54,178

     

     

    $

    38,089

     

     

    $

    88,978

     

     

    $

    72,830

     

    Interest expense

     

    108,051

     

     

     

    108,617

     

     

     

    26,583

     

     

     

    27,124

     

     

     

    54,032

     

     

     

    54,598

     

    Income tax expense

     

    70,413

     

     

     

    64,926

     

     

     

    20,756

     

     

     

    15,094

     

     

     

    34,090

     

     

     

    28,603

     

    Depreciation and amortization

     

    6,780

     

     

     

    6,941

     

     

     

    1,629

     

     

     

    1,731

     

     

     

    3,262

     

     

     

    3,423

     

    EBITDA

    $

    384,918

     

     

    $

    364,010

     

     

    $

    103,146

     

     

    $

    82,038

     

     

    $

    180,362

     

     

    $

    159,454

     

    Equity in (earnings) losses from investments (a)

     

    (1,959

    )

     

     

    (1,262

    )

     

     

    641

     

     

     

    (959

    )

     

     

    (1,497

    )

     

     

    (800

    )

    Equity in losses (earnings) from real estate ventures (b)

     

    10,793

     

     

     

    (2,202

    )

     

     

    1,213

     

     

     

    (2,954

    )

     

     

    11,934

     

     

     

    (1,061

    )

    Loss on extinguishment of debt

     

    368

     

     

     

    549

     

     

     

    —

     

     

     

    40

     

     

     

    —

     

     

     

    181

     

    Stock-based compensation expense (c)

     

    12,482

     

     

     

    10,111

     

     

     

    3,807

     

     

     

    2,644

     

     

     

    7,121

     

     

     

    4,750

     

    Litigation settlement and judgment expense (d)

     

    688

     

     

     

    18,799

     

     

     

    73

     

     

     

    18,105

     

     

     

    264

     

     

     

    18,375

     

    Impact of MSA settlement (e)

     

    (592

    )

     

     

    (734

    )

     

     

    —

     

     

     

    —

     

     

     

    (169

    )

     

     

    (311

    )

    Other, net

     

    (29,678

    )

     

     

    (26,119

    )

     

     

    (5,585

    )

     

     

    (4,791

    )

     

     

    (11,970

    )

     

     

    (8,411

    )

    Adjusted EBITDA

    $

    377,020

     

     

    $

    363,152

     

     

    $

    103,295

     

     

    $

    94,123

     

     

    $

    186,045

     

     

    $

    172,177

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EBITDA by Segment

     

     

     

     

     

     

     

     

     

     

     

    Tobacco

    $

    384,680

     

     

    $

    370,575

     

     

    $

    104,364

     

     

    $

    94,687

     

     

    $

    188,754

     

     

    $

    174,649

     

    Real Estate

     

    18

     

     

     

    313

     

     

     

    (56

    )

     

     

    148

     

     

     

    (85

    )

     

     

    210

     

    Corporate and Other

     

    (7,678

    )

     

     

    (7,736

    )

     

     

    (1,013

    )

     

     

    (712

    )

     

     

    (2,624

    )

     

     

    (2,682

    )

    Total

    $

    377,020

     

     

    $

    363,152

     

     

    $

    103,295

     

     

    $

    94,123

     

     

    $

    186,045

     

     

    $

    172,177

     

    ____________________

    1. Represents equity in (earnings) losses recognized from investments that the Company accounts for under the equity method.
    2. Represents equity in losses (earnings) recognized from the Company's investment in certain real estate ventures that are accounted for under the equity method and are not consolidated in the Company's financial results.
    3. Represents amortization of stock-based compensation.
    4. Represents accruals for litigation in the Tobacco segment.
    5. Represents the Tobacco segment's settlement of long-standing disputes related to the Master Settlement Agreement.

    TABLE 3

    VECTOR GROUP LTD. AND SUBSIDIARIES

    RECONCILIATION OF ADJUSTED NET INCOME

    (Unaudited)

    (Dollars in Thousands, Except Per Share Amounts)

     

     

     

     

     

     

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

     

    June 30,

     

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

     

    2023

     

     

     

     

     

    Net income

    $

    54,178

     

     

    $

    38,089

     

     

    $

    88,978

     

     

    $

    72,830

     

     

     

     

     

     

     

     

     

    Loss on extinguishment of debt

     

    —

     

     

     

    40

     

     

     

    —

     

     

     

    181

     

    Litigation settlement and judgment expense (a)

     

    73

     

     

     

    18,105

     

     

     

    264

     

     

     

    18,375

     

    Impact of MSA settlement (b)

     

    —

     

     

     

    —

     

     

     

    (169

    )

     

     

    (311

    )

    Impact of net interest expense capitalized to real estate ventures

     

    (1,233

    )

     

     

    (1,072

    )

     

     

    1,985

     

     

     

    (2,113

    )

    Total adjustments

     

    (1,160

    )

     

     

    17,073

     

     

     

    2,080

     

     

     

    16,132

     

     

     

     

     

     

     

     

     

    Tax expense (benefit) related to adjustments

     

    293

     

     

     

    (4,407

    )

     

     

    (525

    )

     

     

    (4,164

    )

     

     

     

     

     

     

     

     

    Adjusted Net Income

    $

    53,311

     

     

    $

    50,755

     

     

    $

    90,533

     

     

    $

    84,798

     

     

     

     

     

     

     

     

     

    Per diluted common share:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Net Income applicable to common shares

    $

    0.34

     

     

    $

    0.32

     

     

    $

    0.57

     

     

    $

    0.54

     

    ____________________

    1. Represents accruals for litigation in the Tobacco segment.
    2. Represents the Tobacco segment's settlement of long-standing disputes related to the Master Settlement Agreement.

    TABLE 4

    VECTOR GROUP LTD. AND SUBSIDIARIES

    RECONCILIATION OF ADJUSTED OPERATING INCOME

    (Unaudited)

    (Dollars in Thousands)

     

     

     

     

     

     

     

     

     

     

     

    LTM

     

    Year Ended

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

     

    December 31,

     

    June 30,

     

    June 30,

     

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

    2023

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

     

     

     

    Operating income

    $

    357,662

     

     

    $

    328,035

     

     

    $

    97,786

     

    $

    71,643

     

    $

    175,567

     

     

    $

    145,940

     

     

     

     

     

     

     

     

     

     

     

     

     

    Litigation settlement and judgment expense (a)

     

    688

     

     

     

    18,799

     

     

     

    73

     

     

    18,105

     

     

    264

     

     

     

    18,375

     

    Impact of MSA settlement (b)

     

    (592

    )

     

     

    (734

    )

     

     

    —

     

     

    —

     

     

    (169

    )

     

     

    (311

    )

    Total adjustments

     

    96

     

     

     

    18,065

     

     

     

    73

     

     

    18,105

     

     

    95

     

     

     

    18,064

     

     

     

     

     

     

     

     

     

     

     

     

     

    Adjusted Operating Income

    $

    357,758

     

     

    $

    346,100

     

     

    $

    97,859

     

    $

    89,748

     

    $

    175,662

     

     

    $

    164,004

     

    ____________________

    1. Represents accruals for litigation in the Tobacco segment.
    2. Represents the Tobacco segment's settlement of long-standing disputes related to the Master Settlement Agreement.

    TABLE 5

    VECTOR GROUP LTD. AND SUBSIDIARIES

    RECONCILIATION OF TOBACCO ADJUSTED OPERATING INCOME

    AND TOBACCO ADJUSTED EBITDA

    (Unaudited)

    (Dollars in Thousands)

     

     

    LTM

     

    Year Ended

     

    Three Months Ended

     

    Six Months Ended

     

    June 30,

     

    December 31,

     

    June 30,

     

    June 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

    2023

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

    Tobacco Adjusted Operating Income:

     

     

     

     

     

     

    Operating income from Tobacco segment

    $

    378,878

     

    $

    346,673

     

    $

    102,927

    $

    75,122

    $

    185,926

     

    $

    153,721

     

     

     

     

     

     

     

     

    Litigation settlement and judgment expense (a)

     

    688

     

     

    18,799

     

     

    73

     

    18,105

     

    264

     

     

    18,375

     

    Impact of MSA settlement (b)

     

    (592

    )

     

    (734

    )

     

    —

     

    —

     

    (169

    )

     

    (311

    )

    Total adjustments

     

    96

     

     

    18,065

     

     

    73

     

    18,105

     

    95

     

     

    18,064

     

     

     

     

     

     

     

     

    Tobacco Adjusted Operating Income

    $

    378,974

     

    $

    364,738

     

    $

    103,000

    $

    93,227

    $

    186,021

     

    $

    171,785

     

     
     

     

    LTM

     

    Year Ended

     

    Three Months Ended

     

    Six Months Ended

     

    June 30,

     

    December 31,

     

    June 30,

     

    June 30,

     

     

    2024

     

     

     

    2023

     

     

     

    2024

     

     

    2023

     

     

    2024

     

     

     

    2023

     

     

     

     

     

     

     

     

    Tobacco Adjusted EBITDA:

     

     

     

     

     

     

    Operating income from Tobacco segment

    $

    378,878

     

    $

    346,673

     

    $

    102,927

    $

    75,122

    $

    185,926

     

    $

    153,721

     

     

     

     

     

     

     

     

    Litigation settlement and judgment expense (a)

     

    688

     

     

    18,799

     

     

    73

     

    18,105

     

    264

     

     

    18,375

     

    Impact of MSA settlement (b)

     

    (592

    )

     

    (734

    )

     

    —

     

    —

     

    (169

    )

     

    (311

    )

    Total adjustments

     

    96

     

     

    18,065

     

     

    73

     

    18,105

     

    95

     

     

    18,064

     

     

     

     

     

     

     

     

    Tobacco Adjusted Operating Income

     

    378,974

     

     

    364,738

     

     

    103,000

     

    93,227

     

    186,021

     

     

    171,785

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

    5,500

     

     

    5,686

     

     

    1,298

     

    1,419

     

    2,610

     

     

    2,796

     

    Stock-based compensation expense

     

    206

     

     

    151

     

     

    66

     

    41

     

    123

     

     

    68

     

    Total adjustments

     

    5,706

     

     

    5,837

     

     

    1,364

     

    1,460

     

    2,733

     

     

    2,864

     

     

     

     

     

     

     

     

    Tobacco Adjusted EBITDA

    $

    384,680

     

    $

    370,575

     

    $

    104,364

    $

    94,687

    $

    188,754

     

    $

    174,649

     

     

    ____________________

    1. Represents accruals for litigation in the Tobacco segment.
    2. Represents the Tobacco segment's settlement of long-standing disputes related to the Master Settlement Agreement.

    TABLE 6

    VECTOR GROUP LTD. AND SUBSIDIARIES

    RECONCILIATION OF REVENUES

    (Unaudited)

    (Dollars in Thousands)

     

     

     

    LTM

     

    Year Ended

     

    Three Months Ended

     

    Six Months Ended

     

     

    June 30,

     

    December 31,

     

    June 30,

     

    June 30,

     

     

    2024

     

    2023

     

    2024

     

    2023

     

    2024

     

    2023

    Revenues:

     

     

     

     

     

     

     

     

     

     

     

     

    Tobacco (a)

     

    $

    1,420,942

     

    $

    1,424,268

     

    $

    371,914

     

    $

    365,662

     

    $

    696,481

     

    $

    699,807

    ____________________

    1. Tobacco segment revenues include federal excise taxes of $467,970 for the last twelve months ended June 30, 2024, $486,263 for the year ended December 31, 2023, and $120,452, $226,275, $126,750, and $244,568 for the three and six months ended June 30, 2024 and 2023, respectively.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240731592504/en/

    Get the next $VGR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VGR

    DatePrice TargetRatingAnalyst
    3/31/2022$12.00 → $16.00Equal Weight → Overweight
    Barclays
    11/15/2021$13.00 → $17.00Underweight → Equal Weight
    Barclays
    11/9/2021$18.00Perform → Outperform
    Oppenheimer
    9/13/2021$15.00 → $13.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $VGR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hims & Hers Health Set to Join S&P SmallCap 600

      NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

      10/4/24 6:05:00 PM ET
      $HIMS
      $SPGI
      $VGR
      Medical/Nursing Services
      Health Care
      Finance: Consumer Services
      Finance
    • Vector Group Announces Agreement to be Acquired by JT Group

      Delivers significant value for stockholders while positioning Vector Group for long-term success Vector Group Ltd. (NYSE:VGR) today announced that it has entered into a definitive agreement to be acquired by JT Group, a global company headquartered in Tokyo, Japan, operating in tobacco, pharmaceuticals and processed food. JT Group's global tobacco business, headquartered in Geneva, Switzerland, manufactures and sells some of the world's best-known brands in over 130 markets worldwide – including Winston and Camel (outside the U.S.), as well as MEVIUS and LD. Under the terms of the agreement, JT Group will offer to acquire all outstanding shares of Vector Group common stock for $15.00 pe

      8/21/24 6:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on September 12, 2024, to holders of record as of August 30, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240819252290/en/

      8/20/24 3:08:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    $VGR
    Financials

    Live finance-specific insights

    See more
    • Vector Group Declares Quarterly Cash Dividend

      Vector Group Ltd. (NYSE:VGR) today announced that its Board of Directors has declared a regular quarterly cash dividend on its common stock of $0.20 per share. The quarterly cash dividend will be payable on September 12, 2024, to holders of record as of August 30, 2024. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240819252290/en/

      8/20/24 3:08:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Reports Second Quarter 2024 Financial Results

      Montego maintains position as largest discount brand in the U.S. Second Quarter 2024 Highlights: Consolidated revenues of $371.9 million, up 1.7% or $6.3 million compared to the prior year period. Tobacco segment wholesale market share increased to 5.7% from 5.4% in the prior year period and retail market share remained at 5.8%, unchanged from the prior year period. Montego wholesale and retail market share both increased to 4.1% from 3.4% and 3.5%, respectively, in the prior year period. Operating income of $97.8 million, up 36.5% or $26.1 million compared to the prior year period. Tobacco segment operating income of $102.9 million, up 37.0% or $27.8 million compared to t

      7/31/24 4:45:00 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group to Host Second Quarter 2024 Results Conference Call

      Vector Group Ltd. (NYSE:VGR) will conduct a conference call and webcast to discuss its second quarter 2024 results on Thursday, August 1, 2024 at 8:00 a.m. (ET). Investors may access the call via live webcast at https://www.webcaster4.com/Webcast/Page/2271/50954. Please join the webcast at least 10 minutes prior to start time. A replay of the call will be available shortly after the call ends on August 1, 2024 through August 15, 2024 at https://www.webcaster4.com/Webcast/Page/2271/50954. Vector Group is a holding company for Liggett Group LLC, Vector Tobacco LLC and New Valley LLC. Additional information concerning the company is available on the Company's website, www.VectorGroupLtd.

      7/25/24 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    $VGR
    Leadership Updates

    Live Leadership Updates

    See more
    • Hims & Hers Health Set to Join S&P SmallCap 600

      NEW YORK, Oct. 4, 2024 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE:HIMS) will replace Vector Group Ltd (NYSE:VGR) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, October 9. JT Group is acquiring Vector Group in a deal expected to close soon pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector October 9, 2024 S&P SmallCap 600 Addition Hims & Hers Health HIMS Health Care S&P SmallCap 600 Deletion Vector Group VGR Consumer Staples For more information about S&P Dow Jones Indices, please visit www.spdji.com

      10/4/24 6:05:00 PM ET
      $HIMS
      $SPGI
      $VGR
      Medical/Nursing Services
      Health Care
      Finance: Consumer Services
      Finance
    • Douglas Elliman Appoints Richard Ferrari as President and CEO of Brokerage for New York City and the Northeast Region

      Yuval Greenblatt and Alfred Renna Promoted to Senior Managing Director of Operations and Senior Managing Director of Sales, Respectively, for Flagship 575 Madison Avenue Office Douglas Elliman, one of the largest residential real estate brokerages in the United States, announced today that real estate veteran Richard Ferrari has joined the firm as President and CEO of Brokerage for New York City and the Northeast Region. In this role, Ferrari, a highly regarded industry expert, will oversee the firm's New York City resale markets, including Manhattan, Brooklyn, Riverdale and Long Island City in Queens. He will also assume responsibility for Elliman's New Jersey, Westchester, Connecticut a

      7/21/21 8:30:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group Appoints Technology Veteran Wilson L. White to its Board of Directors

      Expands Board to 10 Directors with Addition of Silicon Valley Executive Vector Group Ltd. (NYSE:VGR) (the "Company") today announced that it has appointed technology industry veteran, Wilson L. White, to its Board of Directors, effective immediately. Mr. White currently serves as Senior Director of Government Affairs and Public Policy at Google. With Mr. White's appointment, Vector Group's Board expands to 10 directors. "With many years of experience in the technology industry, including government relations and legal expertise, Wilson brings to the Board a unique skillset that will further strengthen Vector Group's commitment to staying at the forefront of our business' rapidly-evolving

      6/22/21 8:00:00 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    $VGR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Vector Grp upgraded by Barclays with a new price target

      Barclays upgraded Vector Grp from Equal Weight to Overweight and set a new price target of $16.00 from $12.00 previously

      3/31/22 7:41:06 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Grp upgraded by Barclays with a new price target

      Barclays upgraded Vector Grp from Underweight to Equal Weight and set a new price target of $17.00 from $13.00 previously

      11/15/21 8:00:05 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Vector Group upgraded by Oppenheimer with a new price target

      Oppenheimer upgraded Vector Group from Perform to Outperform and set a new price target of $18.00

      11/9/21 6:13:20 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    $VGR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $VGR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

      SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

      10/15/24 4:00:16 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

      SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

      10/7/24 8:43:24 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.

      SC 13D/A - VECTOR GROUP LTD (0000059440) (Subject)

      10/1/24 4:27:47 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Watkins Barry returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:41:06 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Officer Bell Marc N was granted 164,500 shares and returned $5,100,000 worth of shares to the company (340,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:14:02 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • Director Sharpe Jean E returned $225,000 worth of shares to the company (15,000 units at $15.00), closing all direct ownership in the company (SEC Form 4)

      4 - VECTOR GROUP LTD (0000059440) (Issuer)

      10/7/24 9:08:43 PM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care

    $VGR
    SEC Filings

    See more
    • SEC Form 15-12G filed by Vector Group Ltd.

      15-12G - VECTOR GROUP LTD (0000059440) (Filer)

      10/17/24 8:00:07 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:04 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form EFFECT filed by Vector Group Ltd.

      EFFECT - VECTOR GROUP LTD (0000059440) (Filer)

      10/8/24 12:15:08 AM ET
      $VGR
      Medicinal Chemicals and Botanical Products
      Health Care